What is Avalo Therapeutics's interest expense?

Avalo Therapeutics (AVTX) reported interest expense of $803K in Q1 2026.

How has Avalo Therapeutics's interest expense changed year-over-year?

Avalo Therapeutics's interest expense decreased by 30.1% year-over-year, from $1.15M to $803K.

What is the long-term trend for Avalo Therapeutics's interest expense?

Over 4 years (2021 to 2025), Avalo Therapeutics's interest expense has grown at a 16.1% compound annual growth rate (CAGR), from -$2.39M to $4.35M.

What does interest expense mean?

Cost of borrowing — interest paid or accrued on bonds, bank loans, credit facilities, finance leases, and other debt obligations.

Avalo Therapeutics AVTX Interest Expense

Interest Expense at other companies

XencorXNCR

$4.7M-45.8%

Absci CorporationABSI

$18K-77.2%

Vera TherapeuticsVERA

$1.82M+1.7%

Arcus BiosciencesRCUS

$3M+200%

ImmunityBio, Inc.IBRX

$13.87M+2.5%

Immunovant, Inc.IMVT

$8.06M+17.0%

Other financials

Income statement

See full

Revenue$59.0K-69.3%

Gross profit$963.0K+8,855%

Operating income-$20.9M-42.5%

Net income-$19.6M-49.3%

EPS (diluted)-$0.98+21.6%

Balance sheet

See full

Cash & equivalents$25.3M-79.8%

Total debt$328.0K-59.1%

Total equity$68.3M-44.3%

Total assets$99.9M-27.9%

Cash flow

See full

Operating cash flow-$17.7M-87.1%

CapEx-—

Free cash flow-$15.0M-444%

Valuation

See full

Market cap$954.59M+1,800%

Enterprise value$929.6M-1,353%

P/S1,909.2×+1,868×

Profitability

See full

Gross margin182%+176pp

Operating margin-15,536.1%-17,275pp

Net margin-7,965.8%-10,750pp

FCF margin-11,123.8%-13,374pp

Returns & leverage

See full

Return on equity-88.8%—

Debt / equity0×0.0×

Current ratio7.7×-14.9×

Where this comes from

Reported directly by Avalo Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:InterestIncomeExpenseNonoperatingNet.

The official record: Avalo Therapeutics’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Avalo Therapeutics's interest expense.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Avalo Therapeutics's interest expense?: Avalo Therapeutics (AVTX) reported interest expense of $803K in Q1 2026.
How has Avalo Therapeutics's interest expense changed year-over-year?: Avalo Therapeutics's interest expense decreased by 30.1% year-over-year, from $1.15M to $803K.
What is the long-term trend for Avalo Therapeutics's interest expense?: Over 4 years (2021 to 2025), Avalo Therapeutics's interest expense has grown at a 16.1% compound annual growth rate (CAGR), from -$2.39M to $4.35M.
What does interest expense mean?: Cost of borrowing — interest paid or accrued on bonds, bank loans, credit facilities, finance leases, and other debt obligations.